Keyphrases
Glioblastoma
100%
Paclitaxel
100%
Biomarkers of Response
100%
Breast Cancer
33%
Therapeutic Agents
33%
Patient Cohort
33%
Phase II Clinical Trial
33%
Predictive Biomarker
33%
Therapeutic Benefits
33%
Novel Biomarkers
33%
Breast Cancer Patients
33%
Whole Genome
33%
Taxanes
33%
Biomarker Candidates
33%
Knockout Screen
33%
CRISPR Knockout
33%
Biomarkers of Susceptibility
33%
Negative Trials
33%
Glioblastoma Cancer
33%
Pharmacology, Toxicology and Pharmaceutical Science
Biological Marker
100%
Paclitaxel
100%
Glioblastoma
80%
Breast Cancer
40%
Taxane
20%
Clinical Trial
20%
Neuroscience
Paclitaxel
100%
Taxane
50%
CRISPR
50%
Biochemistry, Genetics and Molecular Biology
Clinical Trial
100%
CRISPR
100%
Immunology and Microbiology
Clustered Regularly Interspaced Short Palindromic Repeat
100%